This paper is in the following e-collection/theme issue:

JMIR Theme Issue: COVID-19 Special Issue (2453) Drug Repurposing and Off-Label Use (25) Infodemiology and Infoveillance (1350) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1643) Infectious Diseases (non-STD/STI) (1576) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1042) Mass Media/Social Media Communication and Campaigns (462) Outbreak and Pandemic Preparedness and Management (1728) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1518)

Published on in Vol 22, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20044, first published .
Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study

Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study

Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study

Authors of this article:

Kacper Niburski1 Author Orcid Image ;   Oskar Niburski2 Author Orcid Image
Article Authors Cited by (51) Tweetations (296) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.